cro.directory
← Compare landing

MDx CRO vs uBriGene

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryMDx CROuBriGene
SummaryFull-service CRO for IVD manufacturers, medical device companies, and precision medicine sponsors. Offers performance studies under ISO 20916 and ISO 14155, EU MDR/IVDR and FDA regulatory support, and companion diagnostic development.uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.
Services
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Analytical Method Development & Validation
  • Translational Research
  • Companion Diagnostics Development
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Analytical Method Development & Validation
  • Translational Research
ModalitiesData not yet provided.
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Oncology
  • Rare Disease
  • Oncology
PhasesData not yet provided.
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
Locations
  • Barcelona, Barcelona, Spain
  • Madrid, Madrid, Spain
  • London, London, United Kingdom
  • Lisbon, Lisbon, Portugal
  • Headquarters, Maryland, Maryland, USA
  • Boston, Boston, Massachusetts, USA
  • Worcester, Worcester, Massachusetts, USA
CertificationsData not yet provided.
  • FDA · Identifier: 20+ INDs filed and accepted
  • EMA · Identifier: 20+ INDs filed and accepted
  • NMPA · Identifier: 20+ INDs filed and accepted

Find similar companies

MDx CRO alternatives · uBriGene alternatives

Markdown mirror: /compare/mdxcro/ubrigene.md